Background: More than half of patients with ischemic stroke experience futile reperfusion, increasing the risk of death and disabilities despite a successful recanalization. The reason behind this is debated, and we aim to investigate cerebrovascular changes toward a broader understanding of these conditions. We hypothesize that ischemic stroke reperfusion modifies the expression profile in the microvasculature in a spatial manner toward peri-infarct brain edema and circulatory failure.

Methods: We investigated the early (24-hour) changes in spatial gene expression in the brain parenchymal endothelial cells and mural cells following ischemia stroke reperfusion in 13- to 14-week-old C57BL/6JRj male mice (n=5). Ischemia was induced by occlusion of the middle cerebral artery for 60 minutes, and Nissl staining was used to validate infarct size. Spatial transcriptomics complemented by bulk proteomics was conducted in the peri-infarct cortex region and validated with immunohistochemical semiquantification of proteins of interest. To avoid individual biological variations, changes in the peri-infarct cortex region were expressed relatively to the matching contralateral hemisphere region.

Results: Ischemic stroke reperfusion impaired the blood-brain barrier integrity through junctional (claudin-5) downregulation, changes of the actin cytoskeleton adhesion, and high expression of the proinflammatory (interleukin-6). Molecules important for extracellular Ca influx and intracellular Ca release, (R-type Ca ), , , , and (inositol-trisphosphate 3-kinase A), were markedly reduced. Furthermore, reduced (glutamate receptor 5) associated with upregulated and implicates suppression of the contractile phenotype, suggesting reduced poststroke vascular resistance due to loss of mural cell tone. The complete spatial transcriptomics map over the ipsilateral and contralateral hemispheres is available online as a Web tool.

Conclusions: Emphasizing the spatial molecular pattern behind blood-brain barrier disruption and loss of the vascular tone in the acute phase following ischemic stroke reperfusion suggests the gene expression contribution for a therapeutic target in ischemia-reperfusion abnormalities.

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.124.048085DOI Listing

Publication Analysis

Top Keywords

ischemic stroke
20
stroke reperfusion
20
spatial transcriptomics
12
gene expression
8
peri-infarct cortex
8
cortex region
8
blood-brain barrier
8
spatial
6
stroke
6
reperfusion
6

Similar Publications

Advances in the detection of biomarkers for ischemic stroke.

Front Neurol

February 2025

Center for Clinical Laboratory, General Hospital of the Yangtze River Shipping, Wuhan Brain Hospital, Wuhan, Hubei, China.

Ischemic stroke is a leading cause of mortality and morbidity globally. Prompt intervention is essential for arresting disease progression and minimizing central nervous system damage. Although imaging studies play a significant role in diagnosing ischemic stroke, their high costs and limited sensitivity often result in diagnostic and treatment delays.

View Article and Find Full Text PDF

Objectives: COVID-19 is an independent risk factor for ischemic stroke. Studies from early in the pandemic show increased rates of unfavorable recanalization, poor outcomes, and mortality in patients who were COVID-19 positive at the time of mechanical thrombectomy. However, there are currently no studies examining these parameters during the later pandemic when circulating variants were less virulent.

View Article and Find Full Text PDF

Background Hypertension is a risk factor for developing stroke after transient ischemic attack (TIA), yet it is unknown if stroke risk is altered by emergency department (ED) antihypertensive therapy. We aimed to investigate stroke rate in a population of TIA patients presenting with elevated blood pressure in the ED, comparing those who received antihypertensive medication in the ED to those who received no treatment. Secondarily, we aimed to assess the association between ED antihypertensive therapy and intensive care unit (ICU) admit rates, hospital length of stay (LOS), and discharge disposition setting in this population.

View Article and Find Full Text PDF

Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) is the preferred treatment for acute ischemic stroke (AIS). Nevertheless, only approximately half of patients undergoing IVT experience positive outcomes. The objective of the study was to examine the clinical characteristics of patients with AIS and identify predictors for unfavorable clinical outcomes at 3 months after IVT.

View Article and Find Full Text PDF

Background: Although existing studies have reported associations between blood group A and cardiometabolic diseases (CMD), most have focused on dominant inheritance models. However, genome-wide association studies have mostly been based on additive genotypes. This study aims to investigate the association between the blood group A allele and 15 CMD using recessive, dominant, and additive models and identify potential mediators.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!